Medical Device Developments

🎉 The October '24 Edition of Medical Device Developments is here 🎉 📡 The 5G Future - Technological advancements are radically changing how surgeons can conduct surgeries remotely in new and exciting ways. Mischa Dohler spoke with us to explain more. 🖨 A New Dimension in 3D Printing - 3D Printing is everywhere in medical manufacturing. An Excellent new example is so-called VIPS-3DP technology, which allows manufactures to craft devices of remarkable lightness. Yong Huang who developed the technique delves into the details. 💰 Manufacturing Class 3 Devices - Class 3 contract manufacturing is soaring. Encompassing the most complex medical devices - for instance, pacemakers and deep-brain stimulators - research suggests they will enjoy the highest CAGR of any class through the end of the decade. Read the full edition here: https://lnkd.in/g8dHV9ju 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

🤝 BioPorto A/S enters global distribution partnership with Beckman Coulter Diagnostics for acute kidney injury NGAL tests Per the agreement, Beckman Coulter will initially distribute BioPorto’s NGAL test in Europe followed by distribution in the United States pending US Food and Drug Administration (FDA) marketing clearance for ProNephro AKI (NGAL) for use on the Beckman Coulter’s analyzers. The agreement with Beckman Coulter is a significant milestone in the execution of BioPorto’s strategy implemented earlier in 2024 and the Company’s goal to expand its global distribution network for ProNephro AKI (NGAL) and the NGAL Test™ by partnering with leading clinical chemistry instrument manufacturers. Ultimately, this joint commitment will enable more laboratories to rapidly implement the test and increase the serviceable market. Read more online: https://lnkd.in/efxbg5iz 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

📢 Klöckner Pentaplast Launches kpNext® MDR1: Sustainable Medical Device Packaging Film kpNext® MDR1 delivers the same, best-in-class performance as traditional medical device packaging films, including equivalent clarity, device protection, and ease of processing. As a designed for recyclability film, it also reinforces kp’s ongoing commitment to sustainability, while providing an innovative packaging solution tailored specifically for medical devices. This expansion into medical device films follows kp’s recent launch of SecondLife® MD, another groundbreaking Medical Device film made with 50% certified recycled content. Read the full press release here: https://lnkd.in/dcDS5cCg 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

👩💻 Scottish tech company novosound develops world’s first ultrasound blood pressure monitor Built on Novosound’s Slanj platform, the technology follows the company’s previous collaboration at the Texas Medical Centre in Houston and is now poised to revolutionize blood pressure monitoring in wearables. Unlike academic institutions that have focused primarily on laboratory-based development, Novosound has already demonstrated the system in real-world settings, including public spaces. The results, including accuracy data, were presented at the IEEE International Ultrasonics Symposium (IUS) in Taipei in September, further strengthening the credibility of the system. Read more online: https://lnkd.in/em2y-Vji 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

🚪 12 days to go until MEDICA - Leading International Trade Fair opens its doors #COMPAMED24 in Düsseldorf is a leading international trade fair for the medical technology supplier sector. The trade fair offers a comprehensive range of high-quality medical technology components, services and production equipment for the medical industry. In the exhibition halls, the latest innovations in the areas of components, modules, OEM equipment, electrical and electronic components, microtechnology, raw materials, materials and adhesives, Manufacturing of components, Manufacturing of finished products, Services and Manufacturing equipment are presented by about 735 exhibitors. In addition, the two accompanying forums, the COMPAMED HIGH-TECH FORUM and the COMPAMED SUPPLIERS FORUM, offer exciting presentations by experts from the industry and space for professional exchange. Register here: https://lnkd.in/gnTupz_c 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

🏥 Medical Device Developments are thrilled to share this week's LinkedIn newsletter! Designed to bring together the top stories from the last week and deliver them straight in to your inbox. Enjoy! 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

💗 Johnson & Johnson MedTech’s Impella ECP shows safety and efficacy in IDE study The IDE study is the first clinical trial completed on patients supported with Impella ECP, a novel transvalvular axial flow pump with compressible pump architecture. Impella ECP technology is developed by Abiomed, a company of Johnson & Johnson MedTech. The IDE study established the safety and efficacy of Impella ECP in high-risk percutaneous coronary intervention (PCI), with a major adverse cardiac and cerebrovascular events (MACCE) rate of 6.3%. Read more online: https://lnkd.in/e9_MiTst 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

🏥 Medtronic reports positive results from Symplicity Spyral system trial SPYRAL HTN-ON MED is a global, randomised, sham-controlled trial that is examining the effects of blood pressure reduction and the safety of RDN. The trial involves the use of the radiofrequency-based Symplicity Spyral RDN system in hypertensive patients on up to three anti-hypertensive medications. Following the six-month primary endpoint assessment, the study evaluated 24-hour ambulatory systolic blood pressure (ABPM) and office-based systolic blood pressure (OSBP) from baseline through annual follow-ups. Read more online: https://lnkd.in/ekkc9949 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

❄ Paragonix Technologies, Inc. secures FDA 510(k) approval for KidneyVault system KidneyVault represents Paragonix’s first perfusion device and combines its digital monitoring capabilities with portable hypothermic perfusion technology to protect donor kidneys. The portable renal perfusion system is intended for pulsatile hypothermic machine perfusion of kidneys for preservation, transportation, and transplantation into a recipient. It is designed to maintain the donor organ storage temperature between 4°C and 8°C for 24 hours. Read more online: https://lnkd.in/esfwg752 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

💗 Advanced NanoTherapies, Inc reports positive data from trial of SirPlux Duo DCB Additionally, the California-based nanotechnology company has unveiled plans to advance its US early feasibility study (EFS), named DYNAMIC DUO I. SirPlux Duo is an investigational next-generation, front-line therapy intended for minimally invasive catheter interventions. It uses a dual-drug therapy of sirolimus and paclitaxel, designed to improve vessel patency and prevent restenosis. The therapy simultaneously delivers sirolimus and paclitaxel to inhibit cell growth at a higher potency. Read more online: https://lnkd.in/eVfphpdK 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing